LRP5 and osteoporosis-pseudoglioma syndrome: Mutations in the Wnt co-receptor LRP5 can be associated with low (Osteoporosis- Pseudoglioma Syndrome; OPPG OMIM 259770) or high bone mass, depending on whether the mutation is inactivating or activating, respectively [17].